Enzyme provides no-code access to Web3 and allows creators and businesses to develop and implement smart contracts.
Enzyme provides no-code access to Web3 and allows creators and businesses to develop and implement smart contracts. Soon they will let people design smart contract interactions across multiple blockchains.Enzyme is headquartered in New York, United States and was founded in 2020.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 25, 2021 | Pre-seed | $120K | 1 | Techstars | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Techstars | Yes | Pre-seed |